In an industry clouded by complexity, the Navitus Drug Trend Report shines a light on cost and utilization trends in our commercial book of business. By empowering our clients with their data and reference points through this report, they have clarity to better understand the cost and value of their benefit and performance to their goals.
At Navitus, we are proud to publish our 8th annual Drug Trend Report. It’s one of the many ways our transparent, pass-through model gives the clearest view of our industry. Throughout that period, our commercial trend has outperformed industry peers. This is the result of our foundational principles:
- Drive to the lowest net cost: Unlike traditional prescription benefit managers (PBMs), we don’t add cost to the system. We don’t engage in spread pricing, and we don’t create or take margin from rebates and discounts we negotiate.
- True transparency: Not only do we pass 100% of rebates and fees received to clients, but we provide them comprehensive access to their data and audit their pharmacy claims.
People-first approach: The people we serve are at the core of what we do. Behind every member ID is a real person and we strive to ensure they get the medication they need to live their healthiest lives. This is one of the reasons why we consistently receive a rating of Excellent from both our clients and members.
Download the executive summary, read the full report, and view the highlighted success stories